Use various methods to manage the nonmotor adverse effects of dopamine receptor agonists in Parkinson's disease

In this: publication
By this: publisher
In this Subject: Pharmacology

Source: Drugs & Therapy Perspectives, Volume 26, Number 12, 1 December 2010 , pp. 23-26(4)

Buy & download fulltext article:

Price: $32.95 plus tax (Refund Policy)

Abstract:

Dopamine receptor agonists are often used in place of levodopa for the first-line treatment of Parkinson's disease (PD). Although these agents are not associated with motor complications, they do have the potential to worsen nonmotor symptoms of PD, which can be addressed by a number of pharmacological and nonpharmacological interventions.

Keywords: Dopamine-receptor-agonists, adverse reactions; Parkinson's-disease

Document Type: Research article

Publication date: 2010-12-01